3-D Matrix AI Stock Analysis
Want to see JP:7777 full AI Analyst Report?
3-D Matrix (7777) AI Stock Analysis
3-D Matrix
(TSE/TYO:7777)
Strong financial performance from revenue acceleration and emerging profitability is the primary driver, tempered by weak technical momentum; attractive valuation provides additional support.
3-D Matrix (7777) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 310.35M
- Dividend Yield
- ―
- Average Volume (3M)
- 2.17M
- Price to Earnings (P/E)
- 10.4
- Beta (1Y)
- 1.89
- Revenue Growth
- 55.91%
- EPS Growth
- ―
- Country
- Japan
- Employees
- 129
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Biotechnology
3-D Matrix Business Overview & Revenue Model
Company Description
3-D Matrix, Ltd. specializes in pioneering self-assembling peptide technology. Its flagship product, PuraMatrix, is an innovative self-assembling peptide hydrogel with diverse applications across medical fields, including regenerative medicine, cell...
3-D Matrix Financial Statement Overview
Summary
Compelling turnaround with accelerating revenue growth to 98% and shift to profitability by 2026, alongside improved equity, reduced debt, and positive operating cash flows.
Income Statement
85Very PositiveBalance Sheet
75PositiveCash Flow
70Positive| Breakdown | TTM | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.92B | 10.89B | 6.93B | 4.59B | 2.31B | 1.51B |
| Gross Profit | 9.48B | 8.57B | 4.42B | 3.09B | 1.29B | 661.01M |
| EBITDA | 2.54B | 4.17B | -1.25B | 2.18B | 774.69M | 847.23M |
| Net Income | 3.69B | 4.16B | -2.50B | -255.50M | -2.45B | -1.89B |
Balance Sheet | ||||||
| Total Assets | 9.40B | 9.80B | 6.51B | 5.89B | 5.83B | 5.61B |
| Cash, Cash Equivalents and Short-Term Investments | 1.69B | 2.83B | 1.58B | 1.36B | 1.17B | 2.85B |
| Total Debt | 600.00M | 600.00M | 2.94B | 4.17B | 4.37B | 3.67B |
| Total Liabilities | 2.18B | 3.00B | 4.30B | 5.53B | 5.30B | 4.15B |
| Stockholders Equity | 7.22B | 6.80B | 2.22B | 353.31M | 524.77M | 1.46B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 368.89M | -1.73B | -1.90B | -4.60B | -2.92B |
| Operating Cash Flow | 0 | 396.85M | -1.71B | -1.90B | -4.59B | -2.90B |
| Investing Cash Flow | 0 | -42.48M | -33.30M | -29.76M | -81.50M | -79.86M |
| Financing Cash Flow | 0 | 786.49M | 2.01B | 2.06B | 2.96B | 4.66B |
3-D Matrix Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7777, the sentiment is Negative. The current price of 317.00 is below the 20-day moving average (MA) of 350.15, below the 50-day MA of 378.66, and below the 200-day MA of 431.71, indicating a bearish trend. The MACD of -20.84 indicates Positive momentum. The RSI at 37.38 is Neutral, neither overbought nor oversold. The STOCH value of 37.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7777.
3-D Matrix Peers Comparison
Overall Rating
JP:667882Outperform- JP:777769Neutral
JP:684963Neutral
JP:796359Neutral
JP:652358Neutral
JP:454950Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:6678 | 82Outperform | JPY 18.43B | 12.29 | ― | 5.97% | 17.11% | 23.02% |
| JP:7777 | 69Neutral | JPY 41.72B | 10.44 | 63.82% | ― | 55.91% | ― |
| JP:6849 | 63Neutral | JPY 245.91B | 20.56 | ― | 2.11% | -0.18% | -33.38% |
| JP:7963 | 59Neutral | JPY 8.15B | 9.84 | ― | 3.02% | 8.56% | 7.14% |
| JP:6523 | 58Neutral | JPY 178.77B | 17.72 | 5.56% | 3.27% | 2.74% | 145.33% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| JP:4549 | 50Neutral | JPY 71.94B | 39.73 | ― | 2.60% | 3.92% | -52.01% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:7777 | 3-D Matrix | 317.00 | -16.00 | -4.80% | |
| JP:6523 | PHC Holdings Corp. | 1284.00 | 348.51 | 37.25% | |
| JP:4549 | Eiken Chemical Co., Ltd. | 2233.00 | -66.10 | -2.87% | |
| JP:6678 | Techno Medica Co., Ltd. | 2149.00 | 268.90 | 14.30% | |
| JP:6849 | Nihon Kohden Corporation | 1518.50 | -56.00 | -3.56% | |
| JP:7963 | Koken Ltd. | 1656.00 | -140.58 | -7.82% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 07, 2026